The exact mechanisms underlying the metabolic effects of bariatric surgery remain unclear. Here, we demonstrate, using a combination of direct and indirect calorimetry, an increase in total resting metabolic rate (RMR) and specifically anaerobic RMR after Roux-en-Y gastric bypass (RYGB), but not sleeve gastrectomy (SG). We also show an RYGB-specific increase in splanchnic sympathetic nerve activity and “browning” of visceral mesenteric fat. Consequently, selective splanchnic denervation abolishes all beneficial metabolic outcomes of gastric bypass that involve changes in the endocannabinoid signaling within the small intestine. Furthermore, we demonstrate that administration of rimonabant, an endocannabinoid receptor-1 (CB1) inverse agonist, to obese mice mimics RYGB-specific effects on energy balance and splanchnic nerve activity. On the other hand, arachidonoylethanolamide (AEA), a CB1 agonist, attenuates the weight loss and metabolic signature of this procedure. These findings identify CB1 as a key player in energy regulation post-RYGB via a pathway involving the sympathetic nervous system.Published by Elsevier Inc.
About The Expert
Yuanchao Ye
Marwa Abu El Haija
Donald A Morgan
Deng Guo
Yang Song
Aaron Frank
Liping Tian
Ruth A Riedl
Colin M L Burnett
Zhan Gao
Zhiyong Zhu
Shailesh K Shahi
Kasra Zarei
Anne Couvelard
Nicolas Poté
Lara Ribeiro-Parenti
André Bado
Lama Noureddine
Andrew Bellizzi
Paul Kievit
Ashutosh K Mangalam
Leonid V Zingman
Maude Le Gall
Justin L Grobe
Lee M Kaplan
Deborah Clegg
Kamal Rahmouni
Mohamad Mokadem
References
PubMed